|Bid||204.560 x 100|
|Ask||204.610 x 100|
|Day's Range||202.700 - 205.745|
|52 Week Range||136.220 - 207.800|
|PE Ratio (TTM)||24.61|
|Forward Dividend & Yield||3.00 (1.56%)|
|1y Target Est||N/A|
Two Senators strike a major deal on crucial health care subsidies. Republican Senator Lamar Alexander and Democratic Senator Patty Murray reached an agreement to extend cost-sharing subsidies to insurance companies. In exchange, some of the law’s requirements will be dropped. The president liked the deal at first but is now backing away from it. Yahoo Finance’s Alexis Christoforous and Jen Rogers figure out why the president isn’t happy with the progress.
Jim Cramer tracks low-valuation stocks like Johnson & Johnson to argue that the market is cheaper than investors may think.
Anthem plans to launch its own pharmacy-benefit manager, serviced by CVS Health, in 2020 after the conclusion of its contract with Express Scripts.
A bipartisan deal from two senators to stabilize Obamacare by restoring subsidies to health insurers suffered major setbacks on Wednesday with the White House saying President Donald Trump now opposes it and senior Republicans speaking out against it. House of Representatives Speaker Paul Ryan, Senate Finance Committee Chairman Orrin Hatch, Senate Republican leadership member John Thune and others expressed hostility to the deal announced on Tuesday by Republican Lamar Alexander and Democrat Patty Murray.
A U.S. federal judge said on Wednesday he would likely issue a ruling next week on a request from several U.S. states to block President Donald Trump's decision to terminate cost-sharing payments to health ...
Anthem will launch its own pharmacy benefit management business, relying heavily on CVS Health for both back-end processing and retail distribution.
Company stock surged 6.6% in extremely heavy trade, putting it on track for its biggest one-day price gain in 33 years.
As speculation intensifies about a possible entrance by Amazon into the pharmacy business, the insurer says it sees the online giant as a potential distributor of drugs rather than a competitor that could siphon off its prescription benefit management business.
UnitedHealth’s shares gained after it said core insurance and health-services businesses grew in its latest quarter, despite a dent in revenue caused by the company’s decision to pull out of most Affordable ...
The Dow Jones Industrial Average briefly broke above the 23,000-point mark for the first time on Tuesday, driven by strong earnings from UnitedHealth and Johnson & Johnson, but finished the session just below that milestone. The Dow may in the near term have a difficult time sustaining a move above 23,000, said Robert Pavlik, chief market strategist at Boston Private Wealth in New York.
Stocks that moved substantially or traded heavily Tuesday: Morgan Stanley, up 18 cents to $49.12 The company had a better-than-expected third quarter as its wealth management business performed well. Johnson ...